Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Singapore

GSK Looks To India, Singapore

November 2006 | Company Finance Alert

UK-based drugmaker GlaxoSmithKline (GSK) has indicated that in future it will be conducting more of its R&D in Asia, with Singapore and India looking like the company's favoured locations. The company expects to have an Indian-originated compound on the market within five years.

To read the full article, please take a trial.

Related Insight Articles
Second Phase Of Biomedical Initiative Under Way

Companies / Singapore Singapore has completed the first phase of its Biomedical Science (BMS) initiative, and is keen to push on to phase II, which will have government investment of US$1.4bn. Under the initial plans, which...
November 2006
Drug Exports Bounce Back

Companies / Singapore Singapore's volatile pharmaceutical exports sector rose by 60% in September, according to United Overseas Bank (UOB), boosted by strong demand in Europe. Pharmaceuticals are a key growth driver of the...
October 2006
Hospital Operator Parkway Eyes Indian Profits

Companies / Singapore Singapore-based healthcare group Parkway Holdings is expecting its clinics in India to start making profits in 2007, although its medical centres in Vietnam and China will continue to incur losses. Parkway...
September 2006
Singaporean Drug Output Falls

Companies / Singapore A slump in Singapore's biomedical output at the beginning of 2006 has affected the country's overall output for the manufacturing sector. Biomedical production in January 2006 decreased by 35.8% compared...
February 2006
Singapore Market Forecast

Companies / Singapore Overall Market
February 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2010 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS